Skip to main content
SpringerLink
Log in

Effectiveness and safety of calcineurin inhibitor withdrawal in kidney transplantation: a meta-analysis of randomized controlled trials

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The purpose was to compare the effectiveness and safety of calcineurin inhibitors (CNIs) withdrawal and continued therapies in kidney transplant recipients.

Methods

We searched the PubMed, MEDLINE, Springer, Elsevier Science Direct, Cochrane Library and Google Scholar up to May 2014. Risk ratio (RR) or weighted mean difference (WMD) and their 95 % confidence intervals (CIs) were calculated in fixed-effects model or random-effects model when appropriate. Besides, sensitivity analysis was performed based on the addition of sirolimus in initial immunosuppression protocols.

Results

Total seven studies with 1071 kidney transplant recipients received CNIs withdrawal therapy (experimental group) and 792 kidney transplant recipients received CNIs continued therapy (control group) were included in the meta-analysis. The overall estimates of acute rejection rate (RR = 1.64, 95 % CI: 1.19–2.27, P = 0.003), mean measured glomerular filtration rate (WMD = 9.50, 95 % CI = 2.96–16.03, P = 0.004), thrombocytopenia (RR = 3.39, 95 % CI: 2.27–5.05, P < 0.00001) and hypertension (RR = 0.56, 95 % CI: 0.40–0.78, P = 0.0006) showed that there were significant differences between the CNIs withdrawal and continued therapies in kidney transplant recipients, while no significant differences were found between groups in survival rate, graft survival rate, diabetes, hypercholesterolemia, hypertriglyceridemia and malignancies. In addition, two studies, in which sirolimus was not used in initial immunosuppression protocol, were excluded in sensitivity analysis and the results were still consistent with the overall analysis.

Conclusions

CNIs withdrawal therapy in kidney transplant recipients could significantly decrease risk of hypertension and improve glomerular filtration rate, accompanying with increased risk of acute rejection and thrombocytopenia, compared with the CNIs continued therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CNIs:

Calcineurin inhibitors

RCT:

Randomized controlled trials

RR:

Risk ratio

WMD:

Weighted mean difference

References

  1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.

    Article  PubMed  Google Scholar 

  2. Cortazar F, Diaz-Wong R, Roth D, Isakova T. Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantation. Nephrol Dial Transplant. 2013;28(11):2708–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Bellingham JM, Anderson ME, D’Alessandro AM. Successful kidney transplantation from a donation after cardiac death donor with an ileal conduit. Transplant Proc. 2009;41(10):4420–1.

    Article  CAS  PubMed  Google Scholar 

  4. Eknoyan G, Levin NW. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.

    Google Scholar 

  5. de Francisco AL, Pinera C. Challenges and future of renal replacement therapy. Hemodial Int. 2006;10(Suppl 1):S19–23.

    Article  PubMed  Google Scholar 

  6. Roodnat JI, Hilbrands LB, Hene RJ, et al. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Transplantation. 2014;98(1):47–53.

    Article  CAS  PubMed  Google Scholar 

  7. Krejci K, Tichy T, Bachleda P, Zadrazil J. Calcineurin inhibitor-induced renal allograft nephrotoxicity. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154(4):297–306.

    Article  PubMed  Google Scholar 

  8. Tanabe T, Morita K, Fujita H, et al. Long-term clinicopathological impact of calcineurin inhibitor cessation without specific cytoreductive induction in kidney transplantation. Clin Transplant. 2013;27(Suppl 26):9–13.

    Article  PubMed  Google Scholar 

  9. Chapman JR, Nankivell BJ. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain? Nephrol Dial Transplant. 2006;21(8):2060–3.

    Article  CAS  PubMed  Google Scholar 

  10. Naesens M, Lerut E, Damme BV, Vanrenterghem Y, Kuypers DRJ. Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. Am J Transplant. 2007;7(9):2114–23.

    Article  CAS  PubMed  Google Scholar 

  11. Chen GD, Liu XC, Shi L, et al. Calcineurin inhibitor conversion to rapamycin can improve graft function in living donor kidney transplantation with older donors. Transplant Proc. 2013;45(4):1648–50.

    Article  CAS  PubMed  Google Scholar 

  12. Zeier M, Van Der Giet M. Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation? Transpl Int. 2011;24(1):30–42.

    Article  CAS  PubMed  Google Scholar 

  13. Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study G. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Transplantation. 2002;74(11):1560–7.

    Article  CAS  PubMed  Google Scholar 

  14. Stallone G, Di Paolo S, Schena A, et al. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients. Transplantation. 2003;75(7):998–1003.

    Article  CAS  PubMed  Google Scholar 

  15. Grinyo JM, Campistol JM, Paul J, et al. Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation. Am J Transplant. 2004;4(8):1308–14.

    Article  CAS  PubMed  Google Scholar 

  16. Lebranchu Y, Thierry A, Toupance O, et al. Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study. Am J Transplant. 2009;9(5):1115–23.

    Article  CAS  PubMed  Google Scholar 

  17. Schena FP, Pascoe MD, Alberu J, et al. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation. 2009;87(2):233–42.

    Article  CAS  PubMed  Google Scholar 

  18. Hausmann H. [Ernst Unger (1875–1938)—a pioneer in kidney transplantation. On the 50th anniversary of the death of the Berlin surgeon]. Z Arztl Fortbild (Jena). 1988;82(17):843–5.

    CAS  Google Scholar 

  19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  21. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820–6.

    Article  CAS  PubMed  Google Scholar 

  22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Podder H, Podbielski J, Hussein I, Katz S, Van Buren C, Kahan BD. Sirolimus improves the two-year outcome of renal allografts in African-American patients. Transpl Int. 2001;14(3):135–42.

    Article  CAS  PubMed  Google Scholar 

  25. Johnson RW, Kreis H, Oberbauer R, Brattstrom C, Claesson K, Eris J. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation. 2001;72(5):777–86.

    Article  CAS  PubMed  Google Scholar 

  26. Baboolal K. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients. Transplantation. 2003;75(8):1404–8.

    Article  CAS  PubMed  Google Scholar 

  27. Redmond A, Barnes S. Acute renal failure: recognition and treatment in ward patients. Nurs Stand. 2004;18(22):46–53.

    Article  PubMed  Google Scholar 

  28. Sousa M, Linhares M, Salzedas-Netto A, et al. Risk factors of pancreatic graft loss and death of receptor after simultaneous pancreas/kidney transplantation. Paper presented at: Transplantation proceedings, 2014.

  29. de Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis. 2000;35(2):333–46.

    Article  CAS  PubMed  Google Scholar 

  30. Mulay AV, Hussain N, Fergusson D, Knoll GA. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. Am J Transplant. 2005;5(7):1748–56.

    Article  CAS  PubMed  Google Scholar 

  31. Frohn C, Fricke L, Puchta JC, Kirchner H. The effect of HLA-C matching on acute renal transplant rejection. Nephrol Dial Transplant. 2001;16(2):355–60.

    Article  CAS  PubMed  Google Scholar 

  32. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351(26):2715–29.

    Article  CAS  PubMed  Google Scholar 

  33. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pancreas transplantation in the United States, 1996–2005. Am J Transplant. 2007;7(5 Pt 2):1359–75.

    Article  CAS  PubMed  Google Scholar 

  34. Wiederrecht G, Lam E, Hung S, Martin M, Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci. 1993;696:9–19.

    Article  CAS  PubMed  Google Scholar 

  35. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol. 2000;11(10):1910–7.

    CAS  PubMed  Google Scholar 

  36. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation. 1993;55(5):993–5.

    Article  CAS  PubMed  Google Scholar 

  37. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int. 1996;49(2):518–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank all respondents of the study and all the people who give the help for this study.

Conflict of interest

The authors have declared that no competing interests exist.

Author information

Authors and Affiliations

  1. Department of Urology, Institute of Organ Transplantation of PLA, 309th Hospital of PLA, A17 Heishanhu Road, Haidian District, Beijing, 100091, China

    Hongwei Bai, Yeyong Qian, Bingyi Shi, Zhen Wang, Gang Li, Yu Fan, Ming Yuan & Lupeng Liu

Authors
  1. Hongwei Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yeyong Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bingyi Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yu Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ming Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lupeng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bingyi Shi.

Additional information

H. Bai and Y. Qian are co-first authors.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bai, H., Qian, Y., Shi, B. et al. Effectiveness and safety of calcineurin inhibitor withdrawal in kidney transplantation: a meta-analysis of randomized controlled trials. Clin Exp Nephrol 19, 1189–1198 (2015). https://doi.org/10.1007/s10157-015-1109-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1109-z

Keywords

Search

Navigation